Company Analysis

Integra LifeSciences Holdings Corporation (IART)

Nasdaq: IART · Surgical & Medical Instruments & Apparatus · Princeton, NJ · filing with the SEC since 1996
Grade4.9
◀ Past 7.0● Present 4.4▶ Future 3.5

The company now

Integra LifeSciences Holdings Corporation is classed by the SEC under Surgical & Medical Instruments & Apparatus (industry code 3841), based in Princeton, NJ. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $1.6 billion and a loss of $516 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

Where the revenue comes from

fiscal 2025, as filed

Revenue by line of business, fiscal 2025

Line of businessFiscal 2025Fiscal 2024Share of revenue
Codman Specialty Surgical$1.20B$1.14B73.4%
Tissue Technologies$435M$467M26.6%

Revenue by region, fiscal 2025

RegionFiscal 2025Fiscal 2024Share of revenue
United States$1.20B$1.19B73.7%
Asia Pacific$189M$177M11.6%
Europe$163M$158M9.9%
Rest of the World$78.6M$82.7M4.8%

As tagged in its annual report (Form 10-K, filed Feb 26, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.

The desk's written account of this company, its Past, Present and Future, is not on file yet.

How the company works

The desk has not read this company's annual report yet.

The record in brief

The desk has not written this company's report yet.

SI Assistanton IART · research, not advice